SyzOnc Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

SyzOnc General Information

Description

Developer of microenvironment modulators designed for tumour ecosystem modulation. The company's modulators utilize multi-modal human tissue data, matrix biology, phenomics to explore the broader tumour landscape and potential druggable matrix targets, create proprietary cancer type-specific ecosystem models to discover novel biology, enabling users to rapidly compare genetic and compound phenotypes to identify compound starting points.

Contact Information

Website
www.syzonc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2929 Arch Street
  • Floor 4
  • Philadelphia, PA
  • United States
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Automation/Workflow Software
Vertical(s)
Big Data, SaaS, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 2929 Arch Street
  • Floor 4
  • Philadelphia, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SyzOnc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 10-Aug-2026 Completed Generating Revenue
3. Accelerator/Incubator 19-Jun-2026 Completed Generating Revenue
2. Early Stage VC 22-Mar-2024 Completed Generating Revenue
1. University Spin-Out 01-Jan-2023 Completed Startup
To view SyzOnc’s complete valuation and funding history, request access »

SyzOnc Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SyzOnc Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fourthwave (Sacramento) Accelerator/Incubator
Memorial Sloan Kettering Cancer Center Accelerator/Incubator
ACS BrightEdge Corporate Venture Capital Minority
University of Pennsylvania University
To view SyzOnc’s complete investors history, request access »

Ready to get started?

Request a free trial

SyzOnc FAQs

  • When was SyzOnc founded?

    SyzOnc was founded in 2023.

  • Where is SyzOnc headquartered?

    SyzOnc is headquartered in Philadelphia, PA.

  • What is the size of SyzOnc?

    SyzOnc has 5 total employees.

  • What industry is SyzOnc in?

    SyzOnc’s primary industry is Biotechnology.

  • Is SyzOnc a private or public company?

    SyzOnc is a Private company.

  • What is SyzOnc’s current revenue?

    The current revenue for SyzOnc is .

  • Who are SyzOnc’s investors?

    Fourthwave (Sacramento), Memorial Sloan Kettering Cancer Center, ACS BrightEdge, and University of Pennsylvania have invested in SyzOnc.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process